A Pill to Prevent COVID-19 Shows Promise
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
The Pharma Letter21h
Positive Phase III trial results for ensitrelvir
Japan’s Shionogi (TYO: 4507) yesterday delivered a late-breaking scientific oral presentation at the Conference of ...
Medscape16h
Ensitrelvir Shows Promise for COVID-19 Prevention Following Exposure
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...